Knowledge of tumor/blood genomic testing (NGS) and ESR1 mutations in a survey of patients with ER+/HER2-metastatic breast cancer (mBC)

被引：0
|
作者：
Meisel, Jane
Sammons, Sarah L.
Shanahan, Kelly
Pluard, Timothy
Kozlowski, Monica
Carroll, Dominic
Attias, Elizabeth
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-P6-09-02
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P6-09-02
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Estrogen receptor 1 (ESR1) mutations in circulating tumor DNA (ctDNA) from patients with ER+/HER2-metastatic breast cancer (mBC) treated with lasofoxifene or fulvestrant in the ELAINE 1 study
    Goetz, Matthew P.
    Gal-Yam, Einav
    Stover, Daniel
    Sammons, Sarah L.
    Graff, Stephanie L.
    Wang, Grace
    Cristofanilli, Massimo
    Riordan, Gary
    Sloane, Hillary S.
    Carroll, Dominic
    Plourde, Paul V.
    Portman, David J.
    CANCER RESEARCH, 2023, 83 (05)
  • [2] Vaginal and sexual health in patients with ER+/HER2-metastatic breast cancer (mBC)
    Shanahan, Kelly
    Sammons, Sarah
    Meisel, Jane L.
    Pluard, Timothy J.
    Kozlowski, Monica
    Carroll, Dominic
    Attias, Elizabeth
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2023, 30 (12): : 1296 - 1296
  • [3] Estrogen receptor 1 (ESR1) mutations in circulating tumor DNA (ctDNA) from patients with ER+/HER2-metastatic breast cancer (mBC) treated with lasofoxifene plus abemaciclib in the ELAINE 2 study
    Damodaran, Senthil
    Moore, Halle
    O'Sullivan, Ciara C.
    Plourde, Paul V.
    Riordan, Gary
    Sloane, Hillary S.
    Tripathy, Debu
    Carroll, Dominic
    Portman, David J.
    CANCER RESEARCH, 2023, 83 (05)
  • [4] Treatment goals and quality of life (QOL) in a survey of patients with ER+/HER2-metastatic breast cancer (mBC)
    Sammons, Sarah L.
    Meisel, Jane
    Shanahan, Kelly
    Pluard, Timothy
    Kozlowski, Monica
    Carroll, Dominic
    Attias, Elizabeth
    CANCER RESEARCH, 2023, 83 (05)
  • [5] ESR1 mutations in HR+/HER2-metastatic breast cancer: Enhancing the accuracy of ctDNA testing
    Venetis, Konstantinos
    Pepe, Francesco
    Pescia, Carlo
    Cursano, Giulia
    Criscitiello, Carmen
    Frascarelli, Chiara
    Mane, Eltjona
    Russo, Gianluca
    Salimbeni, Beatrice Taurelli
    Troncone, Giancarlo
    Rocco, Elena Guerini
    Curigliano, Giuseppe
    Fusco, Nicola
    Malapelle, Umberto
    CANCER TREATMENT REVIEWS, 2023, 121
  • [6] Targeted therapies for ER+/HER2-metastatic breast cancer
    Yamamoto-Ibusuki, Mutsuko
    Arnedos, Monica
    Andre, Fabrice
    BMC MEDICINE, 2015, 13
  • [7] PIK3CA and ESR1 mutations detected in circulating tumor DNA (ctDNA) are predictive factors for late-line hormone-based therapies in ER+/HER2-metastatic breast cancer (MBC)
    Chen, Tom Wei-Wu
    Dai, Ming-Shen
    Chang, Dwang-Ying
    Lin, Ching-Hung
    Chen, I-Chun
    Wang, Ming-Yang
    Huang, Ling-Yi
    Hsu, An
    Zhuo, De-Wei
    Tan, Kien Thiam
    Lu, Yen-Jung
    Chang, Shu-Han
    Cheng, Ann-Lii
    Lu, Yen-Shen
    CANCER RESEARCH, 2020, 80 (04)
  • [8] Vaginal and vulvar symptoms in patients with ESR1-mutated, ER+/ HER2-metastatic breast cancer by baseline characteristics
    Goldfarb, Shari B.
    Sammons, Sarah
    Meisel, Jane L.
    Pluard, Timothy J.
    Jenkins, Simon N.
    Komm, Barry
    Carroll, Dominic
    Portman, David J.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2023, 30 (12): : 1278 - 1279
  • [9] Baseline genomic alterations and the activity of lasofoxifene (LAS) plus abemaciclib (Abema) in patients with ER+/HER2-metastatic breast cancer (mBC): the ELAINE 2 study
    Damodaran, Senthil
    Cristofanilli, Massimo
    Goetz, Matthew
    O'Sullivan, Ciara
    Riordan, Gary
    Rugo, Hope
    Stover, Daniel
    Wander, Seth
    Carroll, Dominic
    Plourde, Paul V.
    Portman, David J.
    Yam, Einav Nili-Gal
    CANCER RESEARCH, 2024, 84 (09)
  • [10] VAGINAL/VULVAR SYMPTOMS WITH LASOFOXIFENE VERSUS FULVESTRANT IN ESR1-MUTATED, ER+/HER2-METASTATIC BREAST CANCER PATIENTS
    Goldfarb, S. B.
    Sammons, S. L.
    Meisel, J. L.
    Pluard, T. J.
    Jenkins, S. N.
    Komm, B.
    Carroll, D.
    Portman, D. J.
    JOURNAL OF SEXUAL MEDICINE, 2023, 20
12345